Year |
Citation |
Score |
2020 |
Hargrove D, Liang B, Kashfi-Sadabadi R, Joshi GN, Gonzalez-Fajardo L, Glass S, Jay M, Salner A, Lu X. Tumor-mesoporous silica nanoparticle interactions following intraperitoneal delivery for targeting peritoneal metastasis. Journal of Controlled Release : Official Journal of the Controlled Release Society. PMID 33166606 DOI: 10.1016/j.jconrel.2020.11.003 |
0.323 |
|
2019 |
Kashfi‐Sadabad R, Gonzalez‐Fajardo L, Hargrove D, Ahmadi B, Munteanu D, Shahbazmohamadi S, Jay M, Lu X. Contrast Agents: Engineering Multifunctional Gold Decorated Dendritic Mesoporous Silica/Tantalum Oxide Nanoparticles for Intraperitoneal Tumor‐Specific Delivery (Part. Part. Syst. Charact. 4/2019) Particle & Particle Systems Characterization. 36: 1970010. DOI: 10.1002/Ppsc.201970010 |
0.42 |
|
2019 |
Kashfi‐Sadabad R, Gonzalez‐Fajardo L, Hargrove D, Ahmadi B, Munteanu D, Shahbazmohamadi S, Jay M, Lu X. Engineering Multifunctional Gold Decorated Dendritic Mesoporous Silica/Tantalum Oxide Nanoparticles for Intraperitoneal Tumor‐Specific Delivery Particle & Particle Systems Characterization. 36: 1900058. DOI: 10.1002/Ppsc.201900058 |
0.401 |
|
2017 |
Kim J, Luo ZX, Wu Y, Lu X, Jay M. In-Situ Formation of Holmium Oxide in Pores of Mesoporous Carbon Nanoparticles as Substrates for Neutron-Activatable Radiotherapeutics. Carbon. 117: 92-99. PMID 28966368 DOI: 10.1016/J.Carbon.2017.02.085 |
0.361 |
|
2015 |
Huckle JE, Sadgrove MP, Mumper RJ, Jay M. Species-dependent chelation of (241)Am by DTPA Di-ethyl ester. Health Physics. 108: 443-50. PMID 25706138 DOI: 10.1097/Hp.0000000000000230 |
0.301 |
|
2014 |
Sueda K, Sadgrove MP, Huckle JE, Leed MG, Weber WM, Doyle-Eisele M, Guilmette RA, Jay M. Orally administered DTPA penta-ethyl ester for the decorporation of inhaled (241)Am. Journal of Pharmaceutical Sciences. 103: 1563-71. PMID 24619514 DOI: 10.1002/Jps.23932 |
0.307 |
|
2014 |
Yang YT, Di Pasqua AJ, Zhang Y, Sueda K, Jay M. Solid dispersions of the penta-ethyl ester prodrug of diethylenetriaminepentaacetic acid (DTPA): formulation design and optimization studies. Pharmaceutical Development and Technology. 19: 806-12. PMID 24047113 DOI: 10.3109/10837450.2013.836216 |
0.345 |
|
2013 |
Zhang Y, Sadgrove MP, Mumper RJ, Jay M. Radionuclide decorporation: matching the biokinetics of actinides by transdermal delivery of pro-chelators. The Aaps Journal. 15: 1180-8. PMID 23990504 DOI: 10.1208/S12248-013-9527-X |
0.302 |
|
2013 |
Yang YT, Di Pasqua AJ, He W, Tsai T, Sueda K, Zhang Y, Jay M. Preparation of alginate beads containing a prodrug of diethylenetriaminepentaacetic acid. Carbohydrate Polymers. 92: 1915-20. PMID 23399237 DOI: 10.1016/J.Carbpol.2012.11.071 |
0.315 |
|
2013 |
Zhang Y, Sadgrove MP, Sueda K, Yang YT, Pacyniak EK, Kagel JR, Braun BA, Zamboni WC, Mumper RJ, Jay M. Nonaqueous gel for the transdermal delivery of a DTPA penta-ethyl ester prodrug. The Aaps Journal. 15: 523-32. PMID 23389812 DOI: 10.1208/S12248-013-9459-5 |
0.358 |
|
2013 |
Di Pasqua AJ, Yuan H, Chung Y, Kim JK, Huckle JE, Li C, Sadgrove M, Tran TH, Jay M, Lu X. Neutron-activatable holmium-containing mesoporous silica nanoparticles as a potential radionuclide therapeutic agent for ovarian cancer. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 54: 111-6. PMID 23100452 DOI: 10.2967/Jnumed.112.106609 |
0.392 |
|
2012 |
Howard MD, Lu X, Rinehart JJ, Jay M, Dziubla TD. Carboxylesterase-triggered hydrolysis of nanoparticle PEGylating agents. Langmuir : the Acs Journal of Surfaces and Colloids. 28: 12030-7. PMID 22830432 DOI: 10.1021/La302144R |
0.644 |
|
2012 |
Kim JK, Yuan H, Nie J, Yang YT, Leggas M, Potter PM, Rinehart J, Jay M, Lu X. High payload dual therapeutic-imaging nanocarriers for triggered tumor delivery. Small (Weinheim An Der Bergstrasse, Germany). 8: 2895-903. PMID 22777758 DOI: 10.1002/Smll.201200437 |
0.365 |
|
2012 |
Di Pasqua AJ, Huckle JE, Kim JK, Chung Y, Wang AZ, Jay M, Lu X. Preparation of neutron-activatable holmium nanoparticles for the treatment of ovarian cancer metastases. Small (Weinheim An Der Bergstrasse, Germany). 8: 997-1000. PMID 22298503 DOI: 10.1002/Smll.201102488 |
0.404 |
|
2012 |
Howard MD, Lu X, Jay M, Dziubla TD. Optimization of the lyophilization process for long-term stability of solid-lipid nanoparticles. Drug Development and Industrial Pharmacy. 38: 1270-9. PMID 22235767 DOI: 10.3109/03639045.2011.645835 |
0.594 |
|
2012 |
Di Pasqua AJ, Miller ML, Lu X, Peng L, Jay M. Tumor accumulation of neutron-activatable holmium-containing mesoporous silica nanoparticles in an orthotopic non-small cell lung cancer mouse model Inorganica Chimica Acta. 393: 334-336. DOI: 10.1016/J.Ica.2012.06.016 |
0.4 |
|
2011 |
Howard MD, Ponta A, Eckman A, Jay M, Bae Y. Polymer micelles with hydrazone-ester dual linkers for tunable release of dexamethasone. Pharmaceutical Research. 28: 2435-46. PMID 21614636 DOI: 10.1007/S11095-011-0470-1 |
0.523 |
|
2011 |
Howard MD, Lu X, Rinehart JJ, Jay M, Dziubla TD. Physicochemical characterization of nanotemplate engineered solid lipid nanoparticles. Langmuir : the Acs Journal of Surfaces and Colloids. 27: 1964-71. PMID 21190351 DOI: 10.1021/La104262K |
0.61 |
|
2011 |
Kim JK, Howard MD, Dziubla TD, Rinehart JJ, Jay M, Lu X. Uniformity of drug payload and its effect on stability of solid lipid nanoparticles containing an ester prodrug. Acs Nano. 5: 209-16. PMID 21158414 DOI: 10.1021/Nn102357Y |
0.622 |
|
2009 |
Sutthanut K, Lu X, Jay M, Sripanidkulchai B. Solid lipid nanoparticles for topical administration of Kaempferia parviflora extracts. Journal of Biomedical Nanotechnology. 5: 224-32. PMID 20055101 DOI: 10.1166/Jbn.2009.1026 |
0.403 |
|
2009 |
Lu X, Howard MD, Talbert DR, Rinehart JJ, Potter PM, Jay M, Leggas M. Nanoparticles containing anti-inflammatory agents as chemotherapy adjuvants II: role of plasma esterases in drug release. The Aaps Journal. 11: 120-2. PMID 19225893 DOI: 10.1208/S12248-009-9086-3 |
0.622 |
|
2008 |
Lu X, Howard MD, Mazik M, Eldridge J, Rinehart JJ, Jay M, Leggas M. Nanoparticles containing anti-inflammatory agents as chemotherapy adjuvants: optimization and in vitro characterization. The Aaps Journal. 10: 133-40. PMID 18446513 DOI: 10.1208/S12248-008-9013-Z |
0.622 |
|
2008 |
Zhu D, Lu X, Hardy PA, Leggas M, Jay M. Nanotemplate-engineered nanoparticles containing gadolinium for magnetic resonance imaging of tumors. Investigative Radiology. 43: 129-40. PMID 18197065 DOI: 10.1097/Rli.0B013E31815878Dd |
0.537 |
|
2006 |
Zhu D, White RD, Hardy PA, Weerapreeyakul N, Sutthanut K, Jay M. Biocompatible nanotemplate-engineered nanoparticles containing gadolinium: stability and relaxivity of a potential MRI contrast agent. Journal of Nanoscience and Nanotechnology. 6: 996-1003. PMID 16736756 DOI: 10.1166/Jnn.2006.169 |
0.622 |
|
2006 |
Zhu D, Mu Z, Mooty C, Kovarik M, Jay M. Suspensions of fluor-containing nanoparticles for quantifying β−-emitting radionuclides in non-hazardous media Journal of Pharmaceutical Innovation. 1: 76-82. DOI: 10.1007/Bf02784883 |
0.55 |
|
2004 |
Oyewumi MO, Yokel RA, Jay M, Coakley T, Mumper RJ. Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice. Journal of Controlled Release : Official Journal of the Controlled Release Society. 95: 613-26. PMID 15023471 DOI: 10.1016/J.Jconrel.2004.01.002 |
0.321 |
|
2003 |
Hsu CH, Cui Z, Mumper RJ, Jay M. Preparation and characterization of novel coenzyme Q10 nanoparticles engineered from microemulsion precursors. Aaps Pharmscitech. 4: E32. PMID 14621964 DOI: 10.1208/Pt040332 |
0.62 |
|
2003 |
Hsu CH, Jay M, Bummer PM, Lehmler HJ. Chemical stability of esters of nicotinic acid intended for pulmonary administration by liquid ventilation. Pharmaceutical Research. 20: 918-25. PMID 12817898 DOI: 10.1023/A:1023899505837 |
0.531 |
|
2001 |
Worthen DR, Jay M, Bummer PM. Methods for the recovery and purification of polyene antifungals. Drug Development and Industrial Pharmacy. 27: 277-86. PMID 11411895 DOI: 10.1081/Ddc-100103727 |
0.635 |
|
Show low-probability matches. |